skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
Material Type:
Article
Add to My Research

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy

Journal of the American College of Cardiology, 2024-04 [Peer Reviewed Journal]

Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2024.03.380 ;PMID: 38597864

Full text available

2
Management of Worsening Heart Failure With Reduced Ejection Fraction
Material Type:
Article
Add to My Research

Management of Worsening Heart Failure With Reduced Ejection Fraction

Journal of the American College of Cardiology, 2023-08, Vol.82 (6), p.559-571 [Peer Reviewed Journal]

2023 The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2023.04.057 ;PMID: 37532426

Full text available

3
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
Material Type:
Article
Add to My Research

GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes

Journal of the American College of Cardiology, 2023-08, Vol.82 (6), p.517-525 [Peer Reviewed Journal]

2023 American College of Cardiology Foundation ;Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2023.05.048 ;PMID: 37532422

Full text available

4
Bridging Treatment Implementation Gaps in Patients With Heart Failure
Material Type:
Article
Add to My Research

Bridging Treatment Implementation Gaps in Patients With Heart Failure

Journal of the American College of Cardiology, 2023-08, Vol.82 (6), p.544-558 [Peer Reviewed Journal]

2023 American College of Cardiology Foundation ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2023.05.050 ;PMID: 37532425

Full text available

5
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
Material Type:
Article
Add to My Research

Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories

Journal of the American College of Cardiology, 2023-05, Vol.81 (19), p.1902-1914 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2023.03.390 ;PMID: 37164523

Full text available

6
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction

Journal of the American College of Cardiology, 2022-09, Vol.80 (12), p.1130-1143 [Peer Reviewed Journal]

2022 The Authors ;info:eu-repo/semantics/openAccess ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.06.037 ;PMID: 36050227

Full text available

7
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age
Material Type:
Article
Add to My Research

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age

Journal of the American College of Cardiology, 2022-07, Vol.80 (1), p.1-18 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.04.040 ;PMID: 35772911

Full text available

8
Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction

Journal of the American College of Cardiology, 2022-03, Vol.79 (12), p.1129-1137 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.01.029 ;PMID: 35331406

Full text available

9
Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy
Material Type:
Article
Add to My Research

Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy

Journal of the American College of Cardiology, 2021-12, Vol.78 (24), p.2439-2453 [Peer Reviewed Journal]

2021 American College of Cardiology Foundation ;Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.10.014 ;PMID: 34886965

Full text available

10
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure
Material Type:
Article
Add to My Research

Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure

Journal of the American College of Cardiology, 2021-09, Vol.78 (13), p.1337-1348 [Peer Reviewed Journal]

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.07.049 ;PMID: 34556320

Full text available

11
Low Blood Pressure and Managing Drugs in HF: Where Do SGLT2 Inhibitors Stand?
Material Type:
Article
Add to My Research

Low Blood Pressure and Managing Drugs in HF: Where Do SGLT2 Inhibitors Stand?

Journal of the American College of Cardiology, 2021-09, Vol.78 (13), p.1349-1351 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.07.050 ;PMID: 34556321

Full text available

12
Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
Material Type:
Article
Add to My Research

Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

Journal of the American College of Cardiology, 2021-09, Vol.78 (13), p.1321-1332 [Peer Reviewed Journal]

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.07.046 ;PMID: 34556318

Full text available

13
Advanced Heart Failure and Angiotensin System Fascinating Complexities
Material Type:
Article
Add to My Research

Advanced Heart Failure and Angiotensin System Fascinating Complexities

Journal of the American College of Cardiology, 2021-08, Vol.78 (5), p.541-542 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.100 ;PMID: 34325846

Full text available

14
Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction
Material Type:
Article
Add to My Research

Omecamtiv Mecarbil: A Personalized Treatment for Patients With Severely Impaired Ejection Fraction

Journal of the American College of Cardiology, 2021-07, Vol.78 (2), p.109-111 [Peer Reviewed Journal]

2021 American College of Cardiology Foundation ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.077 ;PMID: 34015476

Full text available

15
Incidence and Outcomes of Pneumonia in Patients With Heart Failure
Material Type:
Article
Add to My Research

Incidence and Outcomes of Pneumonia in Patients With Heart Failure

Journal of the American College of Cardiology, 2021-04, Vol.77 (16), p.1961-1973 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.03.001 ;PMID: 33888245

Full text available

16
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Material Type:
Article
Add to My Research

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1381-1392 [Peer Reviewed Journal]

2021 The Authors ;Attribution ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.01.033 ;PMID: 33736819

Full text available

17
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1397-1407 [Peer Reviewed Journal]

2021 The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.01.044 ;PMID: 33736821

Full text available

18
Other Things Behind the Low Rate of Heart Failure Trial Publication
Material Type:
Article
Add to My Research

Other Things Behind the Low Rate of Heart Failure Trial Publication

Journal of the American College of Cardiology, 2020-10, Vol.76 (14), p.1716-1717 [Peer Reviewed Journal]

2020 American College of Cardiology Foundation ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.07.062 ;PMID: 33004139

Full text available

19
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
Material Type:
Article
Add to My Research

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF

Journal of the American College of Cardiology, 2020-08, Vol.76 (5), p.503-514 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2020 Elsevier B.V. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.05.072 ;PMID: 32731928

Full text available

20
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction
Material Type:
Article
Add to My Research

Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction

Journal of the American College of Cardiology, 2020-07, Vol.76 (1), p.1-13 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.05.015 ;PMID: 32616150

Full text available

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page

Searching Remote Databases, Please Wait